302 related articles for article (PubMed ID: 18035670)
1. Classification and grading of invasive breast carcinoma.
Elston CW
Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
[TBL] [Abstract][Full Text] [Related]
2. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
3. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
4. Low, intermediate and high grade breast carcinomas as determined by histotyping, immunohistochemical prognosticators and histological grading.
Martinazzi M; Crivelli F; Zampatti C; Pisani P
Pathologica; 1992; 84(1089):33-47. PubMed ID: 1323096
[TBL] [Abstract][Full Text] [Related]
5. A newly proposed semi-automated method of grading invasive lobular carcinoma: a unifying concept and correlation with prognostic markers and patient survival.
Stevens E; Kimler BF; Davis MK; Fan F; Thomas P; Wang XY; Damjanov I; Tawfik OW
Ann Clin Lab Sci; 2009; 39(1):25-31. PubMed ID: 19201737
[TBL] [Abstract][Full Text] [Related]
6. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
Rakha EA; El-Rehim DA; Paish C; Green AR; Lee AH; Robertson JF; Blamey RW; Macmillan D; Ellis IO
Eur J Cancer; 2006 Dec; 42(18):3149-56. PubMed ID: 17055256
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients.
Kurosumi M; Tabei T; Inoue K; Takei H; Ninomiya J; Naganuma R; Suemasu K; Higashi Y; Tsuchiya E
Oncol Rep; 2003; 10(4):833-7. PubMed ID: 12792731
[TBL] [Abstract][Full Text] [Related]
8. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
[TBL] [Abstract][Full Text] [Related]
9. Cytopathological grading, as a predictor of histopathological grade, in ductal carcinoma (NOS) of breast, on air-dried Diff-Quik smears.
Khan MZ; Haleem A; Al Hassani H; Kfoury H
Diagn Cytopathol; 2003 Oct; 29(4):185-93. PubMed ID: 14506669
[TBL] [Abstract][Full Text] [Related]
10. Invasive lobular breast cancer. Prognostic significance of histological malignancy grading.
Talman ML; Jensen MB; Rank F
Acta Oncol; 2007; 46(6):803-9. PubMed ID: 17653904
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of necrosis in Nigerian breast cancer.
Ikpatt O; Ndoma-Egba R; Collan Y
Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
[TBL] [Abstract][Full Text] [Related]
12. Correlation between histological grade and c-erbB2 oncoprotein overexpression in infiltrating ductal carcinoma of breast.
Looi LM; Cheah PL; Yap SF
Malays J Pathol; 1997 Jun; 19(1):35-9. PubMed ID: 10879240
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area.
Raabe NK; Schistad O; Sauer T; Bofin A; Kaaresen R; Fossaa SD
APMIS; 1997 May; 105(5):363-70. PubMed ID: 9201237
[TBL] [Abstract][Full Text] [Related]
14. Invasive cribriform breast carcinomas in patients with grade 1 and stage IIA (T2 N0 M0) breast cancer strongly express the v3 and v6, but not the v4 isoforms of the metastatic marker CD44.
Saleh F; Reno W
Neoplasma; 2008; 55(3):246-55. PubMed ID: 18348657
[TBL] [Abstract][Full Text] [Related]
15. Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?
Adams AL; Chhieng DC; Bell WC; Winokur T; Hameed O
Ann Diagn Pathol; 2009 Aug; 13(4):223-5. PubMed ID: 19608079
[TBL] [Abstract][Full Text] [Related]
16. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 expression in invasive breast carcinomas and clinicopathological correlations.
Comănescu M; Popescu CF
Rom J Morphol Embryol; 2009; 50(3):419-24. PubMed ID: 19690768
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
Bedner E; Harezga B; Osborn M; Domagała W
Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
[TBL] [Abstract][Full Text] [Related]
19. [Histologic classification of breast cancer and its precancerous stages].
Nizze H
Zentralbl Gynakol; 1987; 109(1):3-14. PubMed ID: 3033949
[TBL] [Abstract][Full Text] [Related]
20. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
